Evidence map›Paper›PMID 37995285›Full record

Observational studyRevista medica del Instituto Mexicano del Seguro Social2023

[Availability of mammographs in Mexico: Is it possible to expand coverage].

Isabel Sollozo-Dupont, Héctor Alejandro Galván-Espinoza, Yolanda Villaseñor

Abstract readEnglish AbstractObservational Study
In one paragraph

Observational study in Revista medica del Instituto Mexicano del Seguro Social, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Trends in breast cancer mortality in Mexican women.Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Isabel Sollozo-DupontInstituto Nacional de Cancerología, Subdirección de Servicios Auxiliares de Diagnóstico y Tratamiento. Ciudad de México, México.ORCID 0000-0002-4569-3643
Héctor Alejandro Galván-EspinozaInstituto Nacional de Cancerología, Subdirección de Servicios Auxiliares de Diagnóstico y Tratamiento. Ciudad de México, México.ORCID 0000-0001-9410-3008
Yolanda VillaseñorInstituto Nacional de Cancerología, Subdirección de Servicios Auxiliares de Diagnóstico y Tratamiento. Ciudad de México, México.ORCID 0000-0001-5065-7922

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Breast cancer screening coverage in Mexico is limited. It is necessary to configure the Mexican health system to make it capable of producing more mammograms, without neglecting quality and diagnostic opportunity. Objective: To project the coverage of breast cancer screening programs according to the mammographs availability in the Mexican Health System. Material and methods: An exploratory study was conducted correlating the number mammographs available in the Mexican Health System with women between 40 and 69 who are the target of screening programs in Mexico. The analysis consisted of calculating the coverage of breast cancer screening programs if each mammograph could perform 6336 screening mammograms per year. All the calculations were made with the information of the year 2020 as the most current data in terms of population density. Results: It was determined that the number of mammographs is enough to raise the offer of screening studies to ≈50% at the national level. There are even states whose coverage capacity is projected above 70%. Some of them are Mexico City, Colima, Durango, Quintana Roo, Zacatecas, Baja California Sur and Coahuila. Also, it was observed that the distribution of mammographs is not equitable in the national territory, suggesting investment both in equipment and in screening strategies for breast cancer. Conclusions: Our data show that it is possible to advance in preventing breast cancer in Mexico, although the improvement of the management capacities of the Mexican Health System is required to improve both the coverage and quality of the breast cancer screening programs.

Indexed as

Breast NeoplasmsMammographyEarly Detection of CancerFemaleHumansMass ScreeningMexicoBreast NeoplasmsMammographyMamografíaMexicoNeoplasias de la Mama

Identifiers

PMID37995285
PMCPMC10715020

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.